Detalhe da pesquisa
1.
Trends in nuclear medicine and the radiopharmaceutical sciences in oncology: workforce challenges and training in the age of theranostics.
Lancet Oncol
; 25(6): e250-e259, 2024 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-38821099
2.
Identification of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer by Using HER2-targeted 89Zr-Pertuzumab PET/CT.
Radiology
; 296(2): 370-378, 2020 08.
Artigo
Inglês
| MEDLINE | ID: mdl-32515679
3.
CD38-targeted Immuno-PET of Multiple Myeloma: From Xenograft Models to First-in-Human Imaging.
Radiology
; 295(3): 606-615, 2020 06.
Artigo
Inglês
| MEDLINE | ID: mdl-32255416
4.
Comparison of 68Ga-DOTA-JR11 PET/CT with dosimetric 177Lu-satoreotide tetraxetan (177Lu-DOTA-JR11) SPECT/CT in patients with metastatic neuroendocrine tumors undergoing peptide receptor radionuclide therapy.
Eur J Nucl Med Mol Imaging
; 47(13): 3047-3057, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-32378020
5.
Biodistribution and radiation dose estimates for 68Ga-DOTA-JR11 in patients with metastatic neuroendocrine tumors.
Eur J Nucl Med Mol Imaging
; 46(3): 677-685, 2019 03.
Artigo
Inglês
| MEDLINE | ID: mdl-30374529
6.
Pharmacokinetics and Biodistribution of a [89Zr]Zr-DFO-MSTP2109A Anti-STEAP1 Antibody in Metastatic Castration-Resistant Prostate Cancer Patients.
Mol Pharm
; 16(7): 3083-3090, 2019 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31117485
7.
Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial.
Lancet Oncol
; 19(8): 1040-1050, 2018 08.
Artigo
Inglês
| MEDLINE | ID: mdl-29914796
8.
In Vivo PET Assay of Tumor Glutamine Flux and Metabolism: In-Human Trial of 18F-(2S,4R)-4-Fluoroglutamine.
Radiology
; 287(2): 667-675, 2018 05.
Artigo
Inglês
| MEDLINE | ID: mdl-29388903
9.
A phase II study of radioimmunotherapy with intraventricular 131 I-3F8 for medulloblastoma.
Pediatr Blood Cancer
; 65(1)2018 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-28940863
10.
18F-BMS-986229 PET to Assess Programmed-Death Ligand 1 Status in Gastroesophageal Cancer.
J Nucl Med
; 65(5): 722-727, 2024 May 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38514081
11.
First-in-Human Evaluation of Site-Specifically Labeled 89Zr-Pertuzumab in Patients with HER2-Positive Breast Cancer.
J Nucl Med
; 65(3): 386-393, 2024 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38272704
12.
First-in-human imaging with [89Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumors of the lung and prostate.
medRxiv
; 2024 Jan 11.
Artigo
Inglês
| MEDLINE | ID: mdl-38260492
13.
Noninvasive Assessment of Human Epidermal Growth Factor Receptor 2 (HER2) in Esophagogastric Cancer Using 89Zr-Trastuzumab PET: A Pilot Study.
J Nucl Med
; 64(5): 724-730, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-36418168
14.
Practical considerations for navigating the regulatory landscape of non-clinical studies for clinical translation of radiopharmaceuticals.
EJNMMI Radiopharm Chem
; 7(1): 18, 2022 Jul 19.
Artigo
Inglês
| MEDLINE | ID: mdl-35852679
15.
Phase 1 study of intraventricular 131I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies.
J Hematol Oncol
; 15(1): 165, 2022 11 12.
Artigo
Inglês
| MEDLINE | ID: mdl-36371226
16.
B7H3-Directed Intraperitoneal Radioimmunotherapy With Radioiodinated Omburtamab for Desmoplastic Small Round Cell Tumor and Other Peritoneal Tumors: Results of a Phase I Study.
J Clin Oncol
; 38(36): 4283-4291, 2020 12 20.
Artigo
Inglês
| MEDLINE | ID: mdl-33119478
17.
Preclinical and first-in-human-brain-cancer applications of [18F]poly (ADP-ribose) polymerase inhibitor PET/MR.
Neurooncol Adv
; 2(1): vdaa119, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-33392502
18.
Hyperpolarized MRI of Human Prostate Cancer Reveals Increased Lactate with Tumor Grade Driven by Monocarboxylate Transporter 1.
Cell Metab
; 31(1): 105-114.e3, 2020 01 07.
Artigo
Inglês
| MEDLINE | ID: mdl-31564440
19.
First-in-Humans Imaging with 89Zr-Df-IAB22M2C Anti-CD8 Minibody in Patients with Solid Malignancies: Preliminary Pharmacokinetics, Biodistribution, and Lesion Targeting.
J Nucl Med
; 61(4): 512-519, 2020 04.
Artigo
Inglês
| MEDLINE | ID: mdl-31586002
20.
Safety and Feasibility of PARP1/2 Imaging with 18F-PARPi in Patients with Head and Neck Cancer.
Clin Cancer Res
; 26(13): 3110-3116, 2020 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32245901